EUA
Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay
FDA Emergency Use Authorization · Centers for Disease Control and Prevention (CDC) · Aug 20, 2024
Key facts
| Product | Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay |
|---|---|
| Company | Centers for Disease Control and Prevention (CDC) |
| Product type | Real-time RT-PCR, Multi-analyte, Single Target |
| Date | Aug 20, 2024 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: